• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文会议>International Society of University Colon and Rectal Surgeons >Survival Benefit of Pelvic Exenteration for Locally Advanced Colorectal Cancer with Lymph Node Metastases
【24h】

Survival Benefit of Pelvic Exenteration for Locally Advanced Colorectal Cancer with Lymph Node Metastases

机译：淋巴结转移盆腔盆腔盆腔盆腔出生的生存效益

获取原文
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

We examined the survival benefit of pelvic exenteration for locally advanced colorectal cancer with lymph node metastases, because this issue remains controversial. Medical records of 56 patients who underwent curative pelvic exenteration for colorectal cancer were reviewed retrospectively. Nodal metastases were examined by the clearing method in 29 patients and by the conventional manual method in 27 patients. Invasion to contiguous pelvic organs was present in 45 patients (80.4%) and absent in 11 patients (19.6%). Node metastases were present in 38 patients (67.9%). Operative morbidity and mortality rates were 23.2% (13 patients) and 5.4% (3 patients), respectively. Respective 5-year survival rates were 62.2 and 81.8% in the groups with and without organ invasion (no significant difference). Five-year survival in patients with nodal metastases was 56.4% but was significantly higher, 84.6%, in patients without nodal metastases. Five-year survival in 32 patients with both organ invasion and nodal metastases was 55.6%. Long-term survival was afforded by pelvic exenteration for locally advanced colorectal cancer with nodal metastases.
机译：我们研究了淋巴结转移局部晚期结直肠癌盆腔外切口的存活率，因为这个问题仍然存在争议。回顾性地审查了56例接受过直肠癌治疗骨盆癌症的患者的病历。通过29名患者的清算方法和27例患者的常规手动方法检查节点转移。在45名患者（80.4％）中存在携带连续盆腔器官，11名患者中缺席（19.6％）。 38例患者中存在节点转移（67.9％）。手术发病率和死亡率分别为23.2％（13名患者）和5.4％（3名患者）。各组的5年生存率为62.2和81.8％，群体中有和没有器官入侵（无显着差异）。患者的患者患者的五年生存率为56.4％，但在没有节点转移的患者中显着高出84.6％。 32例患有器官入侵和节点转移的患者的五年生存率为55.6％。通过具有节点转移的局部晚期结直肠癌盆腔出现来提供长期存活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号